Control of arthritis pain with anti-nerve-growth factor: risk and benefit (Q38040648)

27 August 2017

title

Control of arthritis pain with anti-nerve-growth factor: risk and benefit (English)

1 reference

27 August 2017

Matthias F Seidel

1

1 reference

27 August 2017

Nancy E Lane

series ordinal

2

1 reference

27 August 2017

publication date

1 December 2012

1 reference

Current Rheumatology Reports

27 August 2017

published in

1 reference

27 August 2017

volume

14

1 reference

27 August 2017

issue

6

1 reference

27 August 2017

page(s)

583-588

1 reference

Nociception, pain, and antinociception: current concepts

27 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0289-8

Activation of macrophages by substance P: induction of oxidative burst and thromboxane release.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0289-8

The role of endogenous serotonin in adjuvant-induced arthritis in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0289-8

Differential pharmacotherapy for subgroups of fibromyalgia patients with specific consideration of 5-HT3 receptor antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0289-8

Local injections of serotonin type-3 receptor antagonists as a therapeutic option in rheumatology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0289-8

Local pain and spreading hyperalgesia induced by intramuscular injection of nerve growth factor are not reduced by local anesthesia of the muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0289-8

Structural and functional properties of the TRK family of neurotrophin receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0289-8

Nerve growth factor in rheumatic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0289-8

Nerve growth factor induces growth and differentiation of human B lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0289-8

Opposing effects of tumor necrosis factor-alpha and nerve growth factor upon leukotriene C4 production by human eosinophils triggered with N-formyl-methionyl-leucyl-phenylalanine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0289-8

Nerve growth factor: stimulation of polymorphonuclear leukocyte chemotaxis in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0289-8

The NGF saga: from animal models of psychosocial stress to stress-related psychopathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0289-8

Changes in plasma levels of BDNF and NGF reveal a gender-selective vulnerability to early adversity in rhesus macaques

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0289-8

Aggressive behavior induces release of nerve growth factor from mouse salivary gland into the bloodstream

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0289-8

Emotional stress induced by parachute jumping enhances blood nerve growth factor levels and the distribution of nerve growth factor receptors in lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0289-8

Changes in human plasma nerve growth factor level after chronic alcohol consumption and withdrawal.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0289-8

Novel class of pain drugs based on antagonism of NGF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0289-8

Tanezumab for the Treatment of Pain from Osteoarthritis of the Knee

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0289-8

Long-term open-label study of tanezumab for moderate to severe osteoarthritic knee pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0289-8

Preliminary assessment of the safety and efficacy of tanezumab in Japanese patients with moderate to severe osteoarthritis of the knee: a randomized, double-blind, dose-escalation, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0289-8

Nerve growth factor administration protects against experimental diabetic sensory neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0289-8

Effects of nerve growth factor and Noggin-modified bone marrow stromal cells on stroke in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0289-8

Nerve growth factor-induced protection of brain capillary endothelial cells exposed to oxygen-glucose deprivation involves attenuation of Erk phosphorylation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0289-8

Effects of nerve growth factor in primate models of neurodegeneration: potential relevance in clinical neurology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0289-8

Neuroplasticity of sensory and sympathetic nerve fibers in a mouse model of a painful arthritic joint

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0289-8

Expression and function of nerve growth factor and nerve growth factor receptor on cultured keratinocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0289-8

Topical treatment with nerve growth factor for corneal neurotrophic ulcers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0289-8

Nerve growth factor, human skin ulcers and vascularization. Our experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0289-8

The broad spectrum of cytokine gene expression by myoid cells from the human marrow microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0289-8

Expression of neurotrophins and their receptors in human bone marrow

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0289-8

A pilot study evaluating the effect of recombinant human bone morphogenetic protein-2 and recombinant human beta-nerve growth factor on the healing of Class III furcation defects in dogs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0289-8

Nerve growth factor beta(NGF beta) delivery via a collagen/hydroxyapatite (Col/HAp) composite and its effects on new bone ingrowth.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0289-8

Nerve growth factor improves ligament healing

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0289-8

Anti-NGF treatment reduces bone resorption in periodontitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0289-8

The role of neurotrophins in inflammation and allergy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0289-8

p75 neurotrophin receptor suppresses the proliferation of human gastric cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0289-8

Nerve growth factor suppresses prostate tumor growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0289-8

Substance P activates and modulates neutrophil oxidative metabolism and aggregation

21 January 2018

1 reference

12 December 2020

The TNF ligand superfamily and its relevance for human diseases

1 reference

12 December 2020

Mediator release from mast cells by nerve growth factor. Neurotrophin specificity and receptor mediation.

1 reference

12 December 2020

Differential expression of the neurotrophin receptors p75NTR, TrkA, TrkB and TrkC in human peripheral blood mononuclear cells

1 reference

12 December 2020

Specific stimulation of human T lymphocytes by substance P

1 reference

12 December 2020

NGF, a useful tool in the treatment of chronic vasculitic ulcers in rheumatoid arthritis

1 reference

12 December 2020

Expression of nerve growth factor receptors on the ocular surface in healthy subjects and during manifestation of inflammatory diseases

1 reference

12 December 2020

Effects of a monoclonal antibody raised against nerve growth factor on skeletal pain and bone healing after fracture of the C57BL/6J mouse femur

1 reference

12 December 2020

Targeting NGF pathway for developing neuroprotective therapies for multiple sclerosis and other neurological diseases

1 reference

12 December 2020

Selective growth stimulating effects of mouse sarcoma on the sensory and sympathetic nervous system of the chick embryo

1 reference

12 December 2020

Nerve growth factor and Alzheimer's disease

1 reference

12 December 2020

Effect of nerve growth factor on the release of inflammatory mediators by mature human basophils

1 reference

12 December 2020

Human mast cells are capable of serotonin synthesis and release

1 reference

12 December 2020

Rapidly progressive osteoarthritis of the hip.

1 reference

12 December 2020

Serotonin in an antigen-induced arthritis of the rabbit temporomandibular joint

1 reference

12 December 2020

Receptors and antagonists for substance P and related peptides

1 reference

12 December 2020

Efficacy and safety of tanezumab added on to diclofenac sustained release in patients with knee or hip osteoarthritis: a double-blind, placebo-controlled, parallel-group, multicentre phase III randomised clinical trial

1 reference

12 December 2020

Substance P and calcitonin gene related peptide mediate pain in chronic pancreatitis and their expression is driven by nerve growth factor

1 reference

12 December 2020

Expression of neurotrophins and their receptors tropomyosin-related kinases (Trk) under tension-stress during distraction osteogenesis

1 reference

12 December 2020

Nerve growth factor exerts differential effects on the growth of human pancreatic cancer cells

1 reference

12 December 2020

Substance P induces the expression of intercellular adhesion molecule-1 on vascular endothelial cells and enhances neutrophil transendothelial migration

1 reference

12 December 2020

Efficacy and safety of tanezumab in the treatment of chronic low back pain

1 reference

12 December 2020

10.1007/S11926-012-0289-8

Identifiers

DOI

1 reference

Dimensions Publication ID

27 August 2017

1022017988

0 references

1 reference